Latest and Past News
-
Héma-Québec tender selects an extended half-life FVIII
Héma-Québec announced on November 30, following its Request for Proposals for recombinant factor VIII concentrates, that it had selected Esperoct. Esperoct is approved by Health...
-
Hemophilia A gene therapy approved in Europe but possibly delayed in the U.S.
Last August, the European Medicines Agency (EMA) granted conditional marketing authorization to BioMarin’s Roctavian (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A...
-
Hemophilia B gene therapy approved by U.S. FDA
Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene...
-
2023 CHS National Awards
Each year the CHS honours individuals who have made a significant contribution to improving the quality of life of people with bleeding disorders. The 2023...
-
Update on the issue of HIV non-disclosure
HIV Justice News published the following on October 28: “The past two weeks has seen some important HIV Justice advances in three countries – Canada,...
-
Commemoration of the tainted blood tragedy
The tainted blood tragedy is incontestably the worst public health disaster that Canada has ever faced. Today, October 27, anniversary of the creation of the...
-
Unburying My Father: The life and photography of Randy Masser
by Zander Masser, Montreal, QC On a fall day in 1996, my parents called a family meeting. I was 11 years old. My brother was...
-
Hiring now: check out this great career opportunity!
The CHS is hiring a National Community Programs Manager. We would greatly appreciate it if you could share this career opportunity with your network. Thank...
-
CHS Research programs – Time to apply!
The CHS is announcing its Call for Applications for its research programs for the 2023-2024 grant period. The deadline to submit applications for all the...
-
CHS strongly supports CBS’ plasma initiative
Montreal, September 7, 2022 – “The Canadian Hemophilia Society (CHS) strongly supports Canadian Blood Services’ plans to work with a leading company in the plasma...
-
In Memoriam – Janet Conners
The CHS is deeply saddened to hear of the passing on August 20, 2022, of a former Nova Scotia Chapter President, Janet Conners, at age...
-
The CHS attends Newfoundland and Labrador Family Camp 2022
by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the...
-
No change to factor IX product mix in Quebec
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
-
2022 James Kreppner Memorial Scholarship and Bursary Program recipients
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who...